Boehringer Forms Stem Cell Collaboration with China Southeast University

Germany's Boehringer Ingelheim announced a joint research project to treat hearing loss with China Southeast University Institute of Life Sciences in Nanjing. The collaboration combines the work of Professor Renjie Chai at the Institute on the use of stem cells to regrow inner ear hair cells with BI's drug R&D experience. The venture is BI's first human research project in China, and its second Research Beyond Borders project, both of which address hearing loss. BI started the RBB initiative to expand its R&D beyond the company's core treatment areas. More details.... Share this with colleagues: // //